Patent Classification

Drug Delivery System, Aerosol

1. Small particle liposome aerosols for delivery of anticancer drugs
    
2. Small particle liposome aerosols for delivery of anti-cancer drugs
    
3. HFA suspension formulations containing an anticholinergic
    
4. Aerosol drug inhibition of lung metastases
    
5. Inhalation particles incorporating a combination of two or more active ingredients
    
6. Methods of delivering aerosolized polynucleotides to the respiratory tract
    
7. Dry powder for inhalation
    
8. Particulate compositions for pulmonary delivery
    
9. Controlled release insufflation carrier for medicaments
    
10. Storage stable powder compositions of interleukin-4 receptor
     
11. Delivery of opioids through an inhalation route
     
12. Suspension aerosol formulations of pharmaceutical products
     
13. Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
     
14. Pulmonary administration of dry powder formulations for treating infertility
     
15. Delivery of muscle relaxants through an inhalation route
     
16. Suspension aerosol formulations
     
17. Delivery of antihistamines through an inhalation route
     
18. Water stabilized medicinal aerosol formulation
     
19. Particles for inhalation having sustained release properties
     
20. Aerosol delivery systems
     
21. Delivery of beta-blockers through an inhalation route
     
22. Delivery of compounds for the treatment of migraine through an inhalation route
     
23. Milling process for the production of finely milled medicinal substances
     
24. Carrier particles for use in dry powder inhalers
     
25. Delivery of compounds for the treatment of migraine through an inhalation route
     
26. Delivery of stimulants through an inhalation route
     
27. Pulmonary delivery in treating disorders of the central nervous system
     
28. Aerodynamically light particles for pulmonary drug delivery
     
29. Process for preparing powder formulations
     
30. Human medical treatment by aerosol inhalation of immunoglobulin A
     
31. Formulations of steroid solutions for inhalatory administration
     
32. Stable spray-dried protein formulations
     
33. Aerodynamically light particles for pulmonary drug delivery
     
34. Human medical treatment by aerosol inhalation of immunoglobulin A
     
35. Aerosol drug formulations containing hydrofluoroalkanes and alkyl saccharides
     
36. Formulation for inhalation
     
37. Composition for pulmonary administration comprising a drug and a hydrophobic amino acid
     
38. Aerosol formulation containing particulate formoterol, propellant and polar cosolvent
     
39. Storage stable powder compositions of interleukin-4 receptor
     
40. Aerosol composition comprising formoterol
     
41. Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets
     
42. High storage stability inhalable compositions
     
43. High efficient delivery of a large therapeutic mass aerosol
     
44. Delivery of analgesics through an inhalation route
     
45. Systemic administration of a therapeutic preparation
     
46. Inhaleable spray dried 4-helix bundle protein powders having minimized aggregation
     
47. Pulmonary administration of chemically modified insulin
     
48. Liquid droplet aerosols of nanoparticulate drugs
     
49. Delivery of diazepam through an inhalation route
     
50. Delivery of erectile dysfunction drugs through an inhalation route
     
51. Compositions and methods for the pulmonary delivery of aerosolized macromolecules
     
52. Delivery of muscle relaxants through an inhalation route
     
53. Delivery of antidepressants through an inhalation route
     
54. Delivery of stimulants through an inhalation route
     
55. Delivery of opioids through an inhalation route
     
56. Formulation for spray-drying large porous particles
     
57. Stable composition for inhalation therapy comprising delta-9-tetrahydrocannabinol and semiaqueous solvent therefor
     
58. Porous particles comprising excipients for deep lung delivery
     
59. Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route
     
60. Methods and compositions for the pulmonary delivery insulin
     
61. Delivery on nonsteroidal antiinflammatory drugs through an inhalation route
     
62. Pharmaceutical aerosol composition containing HFA 227 and HFA 134a
     
63. Methods and compositions for pulmonary delivery of insulin
     
64. Compositions and methods for the pulmonary delivery of aerosolized medicaments
     
65. Preparation of novel particles for inhalation
     
66. Aerodynamically light particles for pulmonary drug delivery
     
67. Pulmonary delivery in treating disorders of the central nervous system
     
68. Modulated release particles for aerosol delivery
     
69. Method for preparing a viral aerosol
     
70. Inhaleable spray dried 4-helix bundle protein powders having minimized aggregation
     
71. Aerosols containing annealed particulate salbutamol and tetrafluoroethane
     
72. Medicinal aerosol formulation
     
73. Microemulsion aerosol composition
     
74. Aerosol formulations of peptides and proteins
     
75. Devices compositions and methods for the pulmonary delivery of aerosolized medicaments
     
76. Aerodynamically light particles for pulmonary drug delivery
     
77. Stable pharmaceutical budesonide preparation for producing propellant-free aerosols
     
78. Powders comprising anti-adherant materials for use in dry powder inhalers
     
79. Process for the preparation of suspensions of drug particles for inhalation delivery
     
80. Aerodynamically light particles for pulmonary drug delivery
     
81. Stabilization of lipid:DNA formulations during nebulization
     
82. Composition for treating cancer via liposomal aerosol formulation containing taxol
     
83. Method for preparing a viral aerosol and its use in gene therapy treatment
     
84. Liposomal aerosols for delivery of chemotherapeutic retinoids to the lungs
     
85. Pressurized device comprising an ultrafine foaming oil-in-water emulsion and use of this emulsion in cleansing and care of skin
     
86. Pressurized container having an aerosolized pharmaceutical composition
     
87. Aerosol formulations containing micronized optically pure (R,R) formoterol for bronchodilating therapy
     
88. Aerosol pharmaceutical formulation for pulmonary and nasal delivery
     
89. Nebulized aerosols containing nanoparticle dispersions
     
90. Internal liquid composition contained as internal liquid in a releasing container and releasing container product
     
91. Porous particles for deep lung delivery
     
92. Propellant mixtures and aerosols for micronizing medicaments with compressed gas
     
93. Solid particulate propellant systems and aerosol containers employing the same
     
94. Aerosol ointment compositions for topical use
     
95. Pulmonary delivery of protonated/acidified nucleic acids
     
96. Formulations for pulmonary delivery of dopamine agonists
     
97. Pulmonary administration of soluble complement receptor-1 (sCR1) and its derivatives
     
98. Fluorocarbon compositions for pulmonary therapy
     
99. Carrier particles for use in dry powder inhalers
     
100. Aerodynamically light particles for pulmonary drug delivery
      
101. Aerosol package compositions containing fluorinated hydrocarbon propellants
      
102. Aerosol preparation
      
103. Aerosol formulations containing a sugar as a dispersant
      
104. Pressurized aerosol inhalation compositions
      
105. Buccal polar spray or capsule
      
106. Stabilization of lipid:DNA formulations during nebulization
      
107. Small particle liposome aerosols for delivery of anti-cancer drugs
      
108. Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant
      
109. Method and a tobramycin aerosol formulation for treatment prevention and containment of tuberculosis
      
110. Medicinal inhalation aerosol formulations containing budesonide
      
111. Seal configuration for aerosol canister
      
112. Container for aerosol formulation
      
113. Device for delivering an aerosol
      
114. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
      
115. Methods and compositions for pulmonary delivery of insulin
      
116. Compositions and methods for nucleic acid delivery to the lung
      
117. Flunisolide aerosol formulations
      
118. Concentrated aerosol space spray that is not an emulsion

Drug Delivery System, Antacid/Anti-Gas

1. Method of making coated chewing gum products containing various antacids
    
2. Coated chewing gum products containing an antigas agent
    
3. Coated chewing gum products containing antacid and method of making
    
4. Coated chewing gum products containing an acid blocker and process of preparing
    
5. Pharmaceutical antacid
    
6. Antiflatulent composition
    
7. Translucent antacid suspension containing co-dried dihydroxy aluminum sodium carbonate
    
8. Simethicone/anhydrous calcium phosphate compositions
    
9. Pharmaceutical, orally applicable composition
    
10. Simethicone containing pharmaceutical compositions
     
11. Liquid antacid compositions